Click for full image >>
is a biopharmaceutical company focused on the development of
novel treatments for B-cell malignancies and autoimmune diseases.
TG Therapeutics, Inc. Announces Third Quarter 2015 Financial Results and Business Update
TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 57th American Society of Hematology Annual Meeting
3 Columbus Circle, 15th Floor, New York, NY 10019 - P:212.554.4484 - Email Us
Web Site Development by Tidal Media Group